In the News: Pharma Data Protection Rules; Facial Recognition Restrictions; and UBS Fully Owns Its Chinese Operations

China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate facial recognition technology; and UBS becomes the 5th wholly foreign-owned securities firm in China.

Credit: Chexy139/Adobe Stock



China Releases Draft Rules on Data Protection in Pharmaceutical Trials


Chinese authorities have released draft measures to regulate the data protection period of pharmaceutical trials, including those from overseas.

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]